Holdings
Krensavage Asset Management, LLC
As of Sep 30, 2026, Krensavage Asset Management, LLC reported 18 positions worth US$225M. Largest: Enanta Pharmaceuticals, Inc., United Therapeutics Corporation and BioMarin Pharmaceutical Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Enanta Pharmaceuticals, Inc. | 2.87M | US$37.8M | no change | Sep 30, 2026 |
| United Therapeutics Corporation | 66,282 | US$35.9M | −3,000 | Sep 30, 2026 |
| BioMarin Pharmaceutical Inc. | 525K | US$31.5M | no change | Sep 30, 2026 |
| Abbott Laboratories | 200K | US$19.8M | no change | Sep 30, 2026 |
| Exelixis, Inc. | 299K | US$17.5M | −71,300 | Sep 30, 2026 |
| Ultragenyx Pharmaceutical Inc. | 1.14M | US$17.1M | +750K | Sep 30, 2026 |
| Supernus Pharmaceuticals, Inc. | 351K | US$15.1M | +70,000 | Sep 30, 2026 |
| Sanofi SA | 334K | US$13.8M | +10,000 | Sep 30, 2026 |
| Embecta Corp. | 1.14M | US$6.43M | no change | Sep 30, 2026 |
| Ardelyx, Inc. | 1.82M | US$6.21M | +1.28M | Sep 30, 2026 |